FDA Warning: Smoking Cessation Meds
July 1, 2009 by Marijke Durning, RN
Filed under Diseases & Conditions
The stop-smoking market is huge, from the do-it-yourself treatments to alternative medicine to pharmaceutical medicines. Over the past few years, medications like Chantix (varenicline) and Zyban and Wellbutrin (buproprion) have been used by many people, some successfully, some not.
One problem with these medications is that they seem to have an adverse effect on some people who take them and these can be quite serious. According to a press release issued by the FDA:
These symptoms include changes in behavior, hostility, agitation, depressed mood, suicidal thoughts and behavior, and attempted suicide.
Now, the FDA has told the manufacturers that they must add new …read more
Depression Treatment May Help Long Term Improvement Of Glycemic Control
March 8, 2007 by Kendra James, RN
Filed under Diseases & Conditions
Depression affects our physical selves as well as our emotional welfare. I know this from first hand experience. James Robinson of the Salient reports, “The use of anti-depressants grows each year at an increasing and ever-astounding rate. In the United States, the anti-depressant ‘industry’ is worth 14 billion dollars in sales a year.” Could antidepressent treatment provide benefits beyond just mood improvement?
A study of type 2 diabetics with depression confirms that depression has a negative impact on glycemic (blood sugar) control, researchers report, and “affirms the importance of depression management in diabetic …read more




